Innovative development in the world of technology that will change the lives of diabetics
Diabetes is one of the most common chronic diseases in the world. About 25,000 people live in Israel with type 1 diabetes. Professor Amir Tirosh, director of the Institute of Endocrinology and Diabetes at Sheba Medical Center, and Lior Teitler, who took part in the international research, explain on the “Doctors” broadcast about the innovative development that has come to Israel.

Type 1 diabetes, also called juvenile diabetes, is a daily challenge in which patients face a not-so-simple lifestyle, are forced to stab themselves several times a day, monitor their sugar levels, count the amount of carbohydrates at each meal and decide on an appropriate insulin dose – so they are forced Make your own therapeutic decisions around the clock. However, an innovative development that has arrived in Israel can change the lives of diabetics. It is a new technology that makes therapeutic decisions independently, monitors and transmits the dose of insulin that the patient needs automatically 24/7. Want to know more? Watch the mako Facebook broadcast now.

Served as a public service by Medtronic, without involvement in the content.

By Editor

Leave a Reply